600713.SS · 南京医药
China A-shares · RS rating 79 · As of 2026-10-14
| Price | 5.22 CNY |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 79 / 73 / 59 / 75 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 33 / 13 |
| Industry group (rank) | Retail-Drug Stores (16) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +1.0% |
| Distance from 52-week high | +18.4% |
| Market cap (USD) | $980.1M |